Adjuvant Sequencing
Adjuvant Sequencing is a therapeutic strategy in oncology that refers to the structured temporal administration of immunotherapeutic agents following primary cancer treatment to maximize immune-mediated tumor control while minimizing interference with initial therapy efficacy.
10
Publications
438
Citations
102
Authors
63
Institutions
Publications per year
2017–2026
4
Parents
10
Elucidation of the pathway for biosynthesis of saponin adjuvants from the soapbark tree
James Reed, Anastasia Orme, Amr El‐Demerdash et al. · Science · 2023 · 161 citations · Full text
Ingeborg Tinhofer, Volker Budach, Mohammad Saki et al. · European Journal of Cancer · 2016 · 67 citations
1–5 of 10
102
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 102
63
Georgetown Lombardi Comprehensive Cancer Center
Washington, United States
1 h-index
4 publications
48 citations
Paracelsus Medical University
Salzburg, Austria
1 h-index
1 publications
29 citations
Herbert Irving Comprehensive Cancer Center
New York, United States
1 h-index
7 publications
91 citations
Erasmus MC
Rotterdam, The Netherlands
1 h-index
1 publications
14 citations
Occupational Cancer Research Centre
Toronto, Canada
1 h-index
10 publications
250 citations
NewYork–Presbyterian Hospital
New York, United States
1 h-index
7 publications
91 citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
1 h-index
1 publications
12 citations
Miltenyi Biotec (Germany)
Cologne, Germany
1 h-index
1 publications
14 citations
1–8 of 63
2 publications · 46 citations
2
h-index
1 publications · 12 citations
1
h-index
1 publications · 14 citations
1
h-index
1 publications · 31 citations
1
h-index
1 publications · 67 citations
1
h-index
1–5